Literature DB >> 17997176

Optimal health insurance for prevention and treatment.

Randall P Ellis1, Willard G Manning.   

Abstract

This paper reexamines the efficiency-based arguments for optimal health insurance, extending the classic analysis to consider optimal coverage for prevention and treatment separately. Our paper considers the tradeoff between individuals' risk reduction on the one hand, and both ex ante and ex post moral hazard on the other. We demonstrate that it is always desirable to offer at least some insurance coverage for preventive care if individual consumers ignore the impact of their preventive care on the health premium. Using a utility-based framework, we reconfirm the conventional tradeoff between risk avoidance (by risk sharing) and moral hazard for insuring treatment goods. Uncompensated losses that reduce effective income provide a new efficiency-based argument for more generous insurance coverage for prevention and treatment of health conditions. The optimal coinsurance rates for prevention and for treatment are not identical.

Mesh:

Year:  2007        PMID: 17997176     DOI: 10.1016/j.jhealeco.2007.09.002

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  14 in total

1.  A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion.

Authors:  Reza Yaesoubi; Stephen D Roberts
Journal:  Health Care Manag Sci       Date:  2010-08-12

2.  Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.

Authors:  M Christopher Roebuck; Joshua N Liberman
Journal:  Health Serv Res       Date:  2009-01-28       Impact factor: 3.402

3.  Does medication adherence following a copayment increase differ by disease burden?

Authors:  Virginia Wang; Chuan-Fen Liu; Christopher L Bryson; Nancy D Sharp; Matthew L Maciejewski
Journal:  Health Serv Res       Date:  2011-06-20       Impact factor: 3.402

4.  Medical expenditure in urban China: a quantile regression analysis.

Authors:  Jianmei Zhao; Hai Zhong
Journal:  Int J Health Econ Manag       Date:  2015-07-24

5.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

6.  Five questions for health economists.

Authors:  Randall P Ellis
Journal:  Int J Health Care Finance Econ       Date:  2012-09-04

7.  A Welfare Measure of "Offset Effects" in Health Insurance.

Authors:  Jacob Glazer; Thomas G McGuire
Journal:  J Public Econ       Date:  2012-02-25

8.  Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

9.  A Prescription for Drug Formulary Evaluation: An Application of Price Indexes.

Authors:  Jacob Glazer; Haiden A Huskamp; Thomas G McGuire
Journal:  Forum Health Econ Policy       Date:  2012-03-30

10.  Behavioral hazard in health insurance.

Authors: 
Journal:  Natl Bur Econ Res Bull Aging Health       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.